SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis

NCT02696941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Metformin
DRUG: SGLT2 inhibitor

Sponsor

University of Oxford